AC Immune
Series BAC Immune raised €19M in a Series B round in May 2005. The company is based in Lausanne, Switzerland. Data as of Nov 2026.
Amount raised
€19M
€19,000,000
Native amount
19,000,000 EUR
Stage
Series B
series b
Investors
0
Provenance & confidence
UnverifiedAmount
Reported in EUR — no conversion. €19M
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
May 2005
Round type
series b
Amount (EUR)
€19M